comparemela.com

Latest Breaking News On - Dili sim initiative - Page 1 : comparemela.com

U S FDA Renews DILIsym® Software Licenses for 7th Year

Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals .

Linkedinx youtubeBretta howellPaulb watkinsQuantitative systems pharmacology solutions at simulationsDili sim initiativeSimulations plus incExchange commissionSimulations plusScientific advisory boardQuantitative systems pharmacology solutions

Simulations Plus, Inc Announces U S FDA Renews DILIsym Software Licenses

Simulations Plus, Inc. announced that the U.S. FDA has renewed its licenses to the DILIsym software platform. DILIsym is the industry gold standard for quantitative systems toxicology software.

Dili sim initiativeSimulations plus incSimulations plus

Simulations Plus Receives U S FDA Renewal for DILIsym Software Licenses

Provides FDA with software tools to investigate drug-induced liver injury in clinical trials . | April 18, 2023

Bretta howellPaulb watkinsDilisym servicesExchange commissionSimulations plus incDili sim initiativeSimulations plusScientific advisory boardPresident bidenHarbor statement underPrivate securities litigation reform actNc stock exchangePress releaseLinical slp us8292141053

vimarsana © 2020. All Rights Reserved.